Vimarsana
Biggest News Aggregation in the World

Page 3 - Greg Mckee News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Greg Mckee. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Greg Mckee Today - Breaking & Trending Today

Tryp Therapeutics to Present at the H.C. Wainwright Psychedelics Conference on December 6, 2021 - Vimarsana News

Tryp Therapeutics to Present at the H.C. Wainwright Psychedelics Conference on December 6, 2021

/PRNewswire/ -- Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) ("Tryp or the "Company"), a pharmaceutical company focused on developing psilocybin-based...

Tryp Therapeutics Receives Confirmation from FDA to Proceed with Phase 2a Study in Fibromyalgia - Vimarsana News

Tryp Therapeutics Receives Confirmation from FDA to Proceed with Phase 2a Study in Fibromyalgia

/PRNewswire/ -- Tryp Therapeutics (CSE:TRYP) (OTCQB:TRYPF) ("Tryp" or the "Company"), a pharmaceutical company focused on developing psilocybin-based compounds...

Tryp Therapeutics Receives Confirmation from FDA to Proceed with Phase 2a Study in Fibromyalgia - Vimarsana News

Tryp Therapeutics Receives Confirmation from FDA to Proceed with Phase 2a Study in Fibromyalgia

/PRNewswire/ -- Tryp Therapeutics (CSE:TRYP) (OTCQB:TRYPF) ("Tryp" or the "Company"), a pharmaceutical company focused on developing psilocybin-based compounds...

Tryp Therapeutics Inc.: Tryp Therapeutics Reports Clinical Hold on Proposed Phase 2a Study in Eating Disorders - Vimarsana News

Tryp Therapeutics Inc.: Tryp Therapeutics Reports Clinical Hold on Proposed Phase 2a Study in Eating Disorders

San Diego, California--(Newsfile Corp. - October 20, 2021) - Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) ("Tryp" or the "Company"), a pharmaceutical company focused on developing psilocybin-based compounds

Tryp Therapeutics Inc.: Tryp Therapeutics Appoints Dennis Langer, M.D., J.D. as Senior Advisor - Vimarsana News

Tryp Therapeutics Inc.: Tryp Therapeutics Appoints Dennis Langer, M.D., J.D. as Senior Advisor

San Diego, California--(Newsfile Corp. - August 18, 2021) - Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) ("Tryp" or the "Company"), a pharmaceutical company focused on developing psilocybin-based compounds